Treatment Sickle Cell Anemia is a group of disorders that cause red blood cells to become misshapen and break down. Sickle cell disease is the most common inherited blood disorder in the United States, affecting 70,000 to 80,000 Americans (Ashley-Koch, Yang and Olney). Sickle Cell Anemia causes your red blood cells to be thin, stiff, and shaped like a sickle. But your red blood cells are supposed to be round and soft. A person that is diagnosed with sickle cell anemia, their blood cells start to
Sickle cell anemia is a blood disorder that happen very commonly in the African descent. The method of transmission of this disease is inherited by both parent who have (SCD) so when they produce a child the child will have 2 sickle cell genes. There are many statistics on sickle cell anemia. Incidence (annual) of Sickle Cell Anemia: 1 per 500 African American births; 1 per 1,000-1,400 Hispanic-American births (Rados, C. (2003, November 1). Statistics about Sickle Cell Anemia. Retrieved January
disease; Sickle cell anemia, is influenced by ethnicity and ancestry; two key categories that must be considered when explaining genetic associations and comparing traits amongst a population. This article compared the genetic profiles of African Americans with sickle cell disease to individuals of the Caucasian/ European descent and African descent. They discovered that although there is slight genetic comparison between ethnicity, there are more similarity in relation to ancestry and the Sickle cell
Sickle Cell Anemia Sickle cell anemia has been a huge or major controversy in the united states ever since 1973 until today. It is an inherited disease that affects the red blood cells. What is sickle cell Sickle cell anemia is an inherited disease causing red blood cells to malfunction. It is a disorder the affects hemoglobin the protein found in red blood cells. People with this disease genetically inherit this untypical hemoglobin. This means that it cannot be transmitted from one person to
symptoms of Sickle Cell Anemia were observed for over five thousand years in Africa. The first reported case of sickle cell anemia however was in 1846, when an autopsy of a runaway slave showed an absence of a spleen. However, it was first discovered by Ernest Irons, an intern of Dr James B Herrick in the United States in 1910. He viewed an anemic patient’s blood under the microscope and observed “elongated and sickle shaped” red blood cells. However, cases of these sickle shaped red blood cells were of
changes within a single protein may greatly affect the health of a human being and their descendants. Sickle cell blood anemia, or SCA, is a type of blood disorder in which the protein hemoglobin within the affected person have slightly mutated in order to form a sickle shaped cell. This can cause chronic health problems to a patient that has sickle cell anemia since their sickle shaped blood cells may obstruct their circulatory system. Despite this disease being chronic, a patient can only get SCA
Living With Sickle Cell Anemia Introduction According to the 2016 edition of the Oxford dictionary, to define someone or a group of people as vulnerable means that they are susceptible to physical or emotional harm (Vulnerable, 2016). One of the most recognized populations of vulnerable people are children; furthermore, by adding an inherited disease process, that decreases the immune system, would only increase the vulnerability of the population. Children with sickle cell anemia are highly susceptible
B2 Biggs Sickle Cell Anemia Sickle cell anemia, a genetic disease that affects a minority of individuals with African, Indian, and Mediterranean heritage, has been present in Africa for thousands of years, but was only recently “discovered” by countries outside of Africa. The so-called discovery occurred in 1904 when a young African-American dental student complained to Dr. James B. Herrick of chronic pain episodes. Because Dr. Herrick’s speciality was cardiology, he deferred the case to
Sickle cell anemia is an autosomal recessive point mutation that is often attributed to populations in Africa and the Middle East. This is due to a the high occurrence of malaria in these regions, however, the rate at which both sickle cell anemia and malaria are occurring in other regions of the globe is becoming increasingly prevalent. Immigration during the past few decades has resulted in what is now being considered an epidemic. The resources available to treat those with these diseases in more
This paper looks in depth at the disease process of sickle cell anemia. It starts out by covering the pathophysiology of the disease and how it functions within the body. The second section of the paper covers the ways to manage sickle cell anemia, whether it be by medication or blood transfusions, or both. The third section is meant to emphasize the important assessment details and how things should be prioritized for the patient with this disease; it also defines which lab values are most important